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Vpx is a virion-incorporated protein encoded by HIV-2 and certain strains of SIV which is necessary for efficient infection
of lymphocytes and macrophages. To determine the location of Vpx within the HIV-2 particle, core structures were obtained
from mature HIV-2 virions. Analysis of purified cores reveal the presence of monomeric Vpx as well as a nondenaturable
and nonreducible higher order Vpx complex. Characterization of the core-associated Vpx complex suggests it to be a Vpx
homodimer, indicative of high concentrations of Vpx. The incorporation and concentration of Vpx in HIV-2 cores support
the hypothesis that it functions within the viral preintegration complex. q 1996 Academic Press, Inc.
INTRODUCTION Esoda and Boone, 1991; Bowerman et al., 1989; Bukrin-
sky et al., 1993b; Farnet and Haseltine, 1990). A parallel
Virion-incorporated proteins dictate the cellular entry, approach in characterizing the components of retroviral
reverse transcription, nuclear migration, and chromo- preintegration complexes involves purification of the core
somal integration of the retroviral genome. Prior to infec- complexes of retrovirions. Proteins which are not present
tion, the virion core is bounded by a bilipid membrane in the released core structure would not be expected to
which is studded with the viral envelope proteins. The be associated with the presumptive preintegration com-
core structure contains viral nucleic acid as well as re- plex (Bowerman et al., 1989). This approach is biochemi-
verse transcriptase (RT) and integrase (IN) (Borroto- cally more tractable than the isolation of preintegration
Esoda and Boone, 1991; Coffin and Temin, 1971; Roberts complexes due to the ease of collecting and concentrat-
and Oroszlan, 1989; Stromberg et al., 1974; Teramoto et ing large amounts of cell-free virus for use in core purifi-
al., 1977). After retroviral entry into a host cell via direct cation.
fusion, the virion core is released into the cell cytoplasm Human and simian immunodeficiency viruses effi-
leaving the retroviral lipid bilayer and Env proteins fused ciently incorporate two accessory gene products, desig-
to the cell membrane. Retroviral preintegration com- nated Vpr and Vpx, into virion particles. HIV-1 only en-
plexes are derived from these condensed core struc- codes Vpr, while HIV-2 and most SIV strains also encode
tures. Vpx (Myers et al., 1994; Tristem et al., 1992). Although
Besides RT and IN, genetic studies have demonstrated HIV-1 Vpr is efficiently incorporated into particles and
two additional human immunodeficiency virus type 1 facilitates infection of nonproliferating cells such as tis-
(HIV-1) proteins to have roles early in infection, MA and sue macrophages (Balliet et al., 1994; Cohen et al., 1990;
Vpr (Bukrinsky et al., 1993a; Emerman et al., 1994; Gallay Connor et al., 1995; Heinzinger et al., 1994; Paxton et al.,
et al., 1995; Heinzinger et al., 1994; von Schwedler et al., 1993; Westervelt et al., 1992; Yuan et al., 1990), HIV-2 Vpr
1994). Biochemical purification of these proteins from is poorly represented in particles (KewalRamani et al.,
cells newly infected with HIV-1 has demonstrated their 1996) and does not appear to be important for infection
association with viral nucleic acid, consistent with their of macrophages (Dedera et al., 1989; Gibbs et al., 1994;
presence in the viral preintegration complex (Bukrinsky Park and Sodroski, 1995). In contrast, Vpx is efficiently
et al., 1993b; Heinzinger et al., 1994). However, attempts incorporated into virion particles of HIV-2 and SIV (Hen-
to purify HIV preintegration complexes and define their derson et al., 1988; KewalRamani et al., 1996; Wu et al.,
constituents have been hindered by the difficulty in ob- 1994) and, similar to HIV-1 Vpr, facilitates infection of
taining sufficient amounts of preintegration complexes macrophages (Gibbs et al., 1994; Guyader et al., 1989;
for protein characterization and by the apparent biochem- Henderson et al., 1988; Kappes et al., 1991; Kawamura
ical instability of the HIV preintegration complex (Borroto- et al., 1994; Park and Sodroski, 1995; Wu et al., 1994; Yu
et al., 1991).
Current models for HIV infection of nondividing cells1 To whom reprint requests should be addressed at Room C2-023,
such as macrophages hypothesize that proteins neces-Division of Molecular Medicine, Fred Hutchinson Cancer Research
sary for entry of the preintegration complex into the nu-Center, 1124 Columbia St., Seattle, WA 98104. Fax: (206) 667-6523; E-
mail: memerman@fred.fhcrc.org. cleus should be present in virion cores (Heinzinger et
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al., 1994). Therefore, we examined HIV-2 cores for their tions. Cells were seeded into 6-well plates with 35-mm
wells at a density of either 4.5 1 105 293T cells or 2.0 1Vpx content. Initially, we evaluated protocols and deter-
gents which were successful in obtaining cores from 105 HeLa cells per well the day prior to transfection. On
the following day, cells were transfected with 5 mg DNAoncoviruses. We found that purification of HIV-2 cores
is increased nearly 80-fold relative to simple detergent per well by calcium phosphate precipitation (Chen and
Okayama, 1987). One day posttransfection, cells werepreincubation methods by using the ‘‘spin-thru’’ technique
developed for purification of avian myeloblastosis virus washed with PBS and reincubated with normal growth
media. Two days posttransfection, cell supernatantscores (Stromberg, 1972). In contrast to recent reports
using SIVmac (Liska et al., 1994; Yu et al., 1993), we find were collected, clarified, and filtered through a 0.2-mm
membrane. Virus-containing supernatants from 293TVpx and a 30-kDa insoluble form of Vpx to be associated
with HIV-2 cores using the more efficient technique to transfections were layered over 20% sucrose cushions
and centrifuged at 125,000 g for 2 hr at 47. Virion pelletsisolate cores from wild-type virus. Analysis of the core-
associated 30-kDa form of Vpx shows it to be an nonde- were resuspended in Standard buffer (100 mM NaCl, 10
mM Tris–HCl, pH 7.4, 1 mM EDTA) and stored at 0807naturable homodimer. The concentration of Vpx in mono-
meric and multimeric forms in the virion core supports until analysis.
Wild-type and mutant viruses were obtained from shortthe hypothesis that Vpx plays a role early in infection.
term, productive infections of CEMx174 cells with virus
obtained from transfections. Ten to fourteen days afterMATERIALS AND METHODS
infection, infected-cell supernatants were collected, clari-
DNA constructs fied by low-speed centrifugation, and pushed through
0.2-mm filters. Clarified supernatants were sedimentedThe wild-type HIV-2ROD (pROD10) proviral construct
against a 30% cushion of sucrose in an ultracentrifugehas been recently described (Ryan-Graham and Peden,
to obtain virus preparations. These preparations were1995). pROD10vpx1 is isogenic with pROD10 except for
used in the density gradient fractionation analysis.a mutation in the vpx gene which removes its initiation
codon as previously described (Guyader et al., 1989).
Antibodies and immunoblotsThese plasmids are referred to in the text as pHIV-2 and
pHIV-2vpx, respectively. A premature termination codon Polyclonal rabbit antibodies directed toward HIV-2 Vpr
was introduced into vpr of pROD10 by Klenow-mediated and Vpx have been previously described (Guyader et
fill in of a HindIII restriction site within vpr. This clone is al., 1989; KewalRamani et al., 1996). Murine monoclonal
referred to as pHIV-2vpr, and expresses no detectable antibody to HIV-2 p25 (CA) was obtained from the Na-
Vpr (KewalRamani et al., 1996). The vpr mutation in this tional Institutes of Health AIDS Research and Reference
construct does not overlap with other open reading Reagent Program.
frames. The SIVmne proviral expression construct, pMNE8 Denatured and reduced viral lysates were resolved by
(Hu et al., 1993), is referred to as pSIVmne in the text. sodium dodecyl sulfate (SDS)–polyacrylamide gel elec-
The vpr and vpx genes of HIV-2ROD were subcloned trophoresis (PAGE), blotted onto membranes, and probed
into pBlueScript vectors (Stratagene) pT7vpr and pT7vpx, with anti-VpxHIV2 sera diluted 1:2000, anti-CA sera diluted
respectively, for expression of the phage T7 promoter in 1:2000, or anti-HIV-2 diluted 1:200. Horseradish peroxi-
vitro. The bacterial expression construct used to obtain dase (HRP)-conjugated donkey immunoglobulin specific
recombinant Vpx, pMBPVpx, and the eukaryotic expres- for rabbit immunoglobulins (Amersham) was used to de-
sion constructs derived for transient expression of Vpx tect bound anti-VpxHIV2 , goat anti-murine Ig conjugated to
have been described (KewalRamani et al., 1996). pLTR- HRP (Cappel) was used to detect the CAHIV2 monoclonal
VPX is an expression construct derived for transient eu- antibodies, and sheep anti-human Ig conjugated to HRP
karyotic expression of HIV-2 Vpx which utilizes the HIV- (Amersham) was used to detect the HIV-2 antibodies.
2ROD LTR promoter/enhancer driving HIV-2ROD vpx fol- Secondary antibodies were used at a dilution of 1:2000.
lowed by the human hepatitis B virus polyadenylation In order to detect bound secondary antibody, blots were
signal sequence (KewalRamani et al., 1996). treated with Amersham enhanced chemiluminescent
(ECL) reagents. Prior to reprobing blots with alternate
Cell culture, transfections, and virus stocks antibody sets, membranes were incubated shaking in a
solution of strip buffer [2% SDS, 100 mM b-mercaptoetha-
Human 293T cells and HeLa cells were cultured in
nol (b-me) 62.5 mM Tris–HCl, pH 6.8] for 30 min at 657
Dulbecco’s modified Eagle’s medium supplemented with
to remove bound antibodies.
10% fetal bovine serum (FBS). CEMx174 cells were prop-
agated in RPMI 1640 medium supplemented with 10% In vitro translations
FBS and 0.3 g/liter L-glutamine.
To generate virus stocks for analysis of complementa- Coupled in vitro transcriptions and translations of Vpr
and Vpx were performed using either pT7vpr or pT7vpxtion in trans, 293T cells were transiently transfected.
HeLa cells were transfected to generate virus for infec- as transcription template in the Promega T7 TnT system
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with rabbit reticulocyte lysates. Transcripts were trans- bottom of the tube, analyzed for corresponding density
using a refractometer, and assayed for RT activity.lated in the presence of [35S]methionine and cysteine,
trans-label (ICN). Proteins of interest were immunopre- In the second method of core isolation, spin-thru ex-
periments were performed. Sucrose gradients of 20–70%cipitated and resolved by SDS–PAGE.
were preformed (3.5–4 ml) in 12 1 2-in. Beckman polyal-
Reverse transcriptase and p24 antigen capture lomer centrifuge tubes and kept at 47 until use. Gradients
assays were overlaid with a 0.125 ml detergent layer in a concen-
tration of 15% sucrose in Standard buffer. This layer wasRT activity was measured as previously described,
covered with a 0.1-ml cushion of 7.5% sucrose in Stan-modified for HIV (Goff et al., 1981; Guyader et al., 1989).
dard buffer containing no detergent. This layer serves asSamples were mixed with RT reaction mixture (50 mM
a barrier to minimize mixing of the virus and detergentTris–HCl, pH 7.8, 7.5 mM KCl, 2 mM DTT, 5 mM MgCl2 , interfaces prior to centrifugation. Concentrated virus in5 mg/ml polyrA, 1.57 mg/ml oligo(dT), 0.05% NP-40) con-
Standard buffer was placed on top of the barrier layertaining [a-32P]dTTP. After 90-min incubation at 377, reac-
and tubes were immediately prepared for centrifugation.tion mixtures were spotted onto Whatman DE81 paper
Ultracentrifugation was performed in a precooled Beck-and washed. Filters were analyzed using a Molecular
man L7 ultracentrifuge using a Beckman SW55Ti rotor.Dynamics Phosphorimager.
The spin was not initiated until the L7 drew a 1000-mmAssays for HIV-2 p25 capsid proteins were performed
vacuum. This enabled full acceleration from 0 to 36,000using a HIV-1 p24 antigen enzyme-linked immunosorbent
rpm by eliminating the automatic, several-minute pauseassay kit (Coulter, Hialeah, FL). In each experiment, a
at 1500 rpm to establish the vacuum chamber. Thus, thestandard curve was generated by serial dilutions of a
virus preparation enters and passes through the deter-capsid antigen standard provided by the manufacturer.
gent barrier at the quickest possible speed, minimizing
contact time. Centrifugation was performed for 5 hr at 47Core preparations
at 125,000 g. Gradient fractions were collected from the
Generation of retroviral cores requires removal of the bottom of the tube and densities were determined using
lipid bilayer from intact virions through use of an organic a refractometer.
solvent, detergent, lipase, or other technique which re- After optimal virus to detergent conditions were estab-
leases the otherwise enveloped structures. Purification lished, 25–60% sucrose gradients were used for prepar-
of retroviral core structures relies on the differences in ative analysis and larger fractions were collected after
density between intact virions, solubilized virion proteins, centrifugation. A HIV-2 stock which measured a value of
and core structures. Intact retrovirions have a buoyant 100 ng using an ELISA to HIV-1 CA was used in each
density of 1.16 g/ml (Coffin and Temin, 1971; Roberts and spin-thru gradient. After density and RT activity analysis,
Oroszlan, 1989; Stromberg, 1972; Teramoto et al., 1977). fractions were assayed for protein content and presence
However, the density of the encapsidated viral genome of core structures. For immunoblot analysis, protein frac-
is offset by the buoyancy of fatty acid chains constituting tions were precipitated with trichloroacetic acid (TCA) at
the lipid bilayer of the virus. Because virion cores lack a final concentration of 10%. For electron microscopy
lipid membranes, they have an increased density relative (EM) of cores, fractions with densities between 1.22 and
to intact virions. Cores from oncoretroviruses have densi- 1.28 g/ml were diluted 20-fold in standard buffer to dilute
ties ranging from 1.23 to 1.27 g/ml (Coffin and Temin, the sucrose which interferes with EM visualization. After
1971; Liu et al., 1995; Roberts and Oroszlan, 1989; dilution, core preparations were concentrated by ultra-
Stromberg, 1972; Teramoto et al., 1977; Yu et al., 1993). centrifugation and resuspended in Standard buffer. Pel-
In our experiments, denser core material was separated leted fractions were incubated with a gluteraldehyde fix-
from intact or solubilized virions by equilibrium sedimen- ing solution for 1 hr. After fixing, samples were spun onto
tation through a concentration gradient of sucrose in paraffin grids in a Beckman air fuge and stained with 2%
Standard buffer using two different methods. uranyl acetate prior to visualization. All samples were
Prior to fractionation on sucrose gradients, cell-free examined in a JEOL 100SX transmission electron micro-
HIV-2 virus stocks were purified by pelleting through a scope operating at 80 kV.
30% cushion of sucrose at 100,000 g for 2 hr at 47. Con-
centrated virus was quantified by ELISA to CA and frozen
RESULTS
at 0807 prior to fractionation experiments. In the first
core isolation method, fixed amounts of virus were incu- Optimization of HIV-2 core purification
bated with different concentrations of ionic and nonionic
detergents at room temperature or 47 for 10 min. After To determine the localization of HIV-2 Vpx within viri-
ons, we examined techniques which would allow theincubation, detergent-treated virus was laid over 20–70%
(weight/volume) sucrose gradients and sedimented at generation of HIV-2 cores. Techniques to obtain the core
structures of different oncoretroviruses were developed125,000 g for 5 hr at 47 in a swinging bucket rotor. After
centrifugation, sucrose fractions were obtained from the in the 1970s. Most of these techniques relied upon gentle
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solubilization of the viral lipid bilayer such that the struc-
ture of the oncoviral cores was not disturbed. However,
application of these techniques to lentiviruses, with the
exception of the equine infectious anemia virus (Borroto-
Esoda and Boone, 1991; Roberts and Oroszlan, 1989),
require a very large amount of intact virions (Liu et al.,
1995; Yu et al., 1993). In our initial attempts to purify HIV-
2 cores, particles were incubated with various ionic and
nonionic detergents at different detergent to virion pro-
tein concentrations. Because the core structures of re-
troviruses have densities ranging from 1.23 to 1.27 g/ml
and intact particles have a density of approximately 1.16
g/ml (Coffin and Temin, 1971; Liu et al., 1995; Roberts
and Oroszlan, 1989; Stromberg, 1972; Teramoto et al.,
1977; Yu et al., 1993), virus treated with detergent was
sedimented through a 20–70% sucrose gradient to sepa-
rate the denser HIV-2 core structures from intact virions,
wholly disrupted virion proteins, and viral membranes.
Retroviral core complexes are minimally composed of
capsid (CA), reverse transcriptase, and integrase in asso-
ciation with the viral genome. To evaluate the efficacy
of the detergent incubations for core release, sucrose
gradient fractions were analyzed for RT activity or CA
content by antigen capture assay. Very dilute detergent
concentrations [lower than the respective critical micelle
concentration (CMC)] did not solubilize the viral mem-
brane while increasing concentrations resulted in com-
FIG. 1. Efficiency of different detergent protocols in release of HIV-
plete solubilization of the particles such that core pro- 2 cores. (A) Wild-type HIV-2 particles were either preincubated in deter-
teins were only detected in low-density fractions. Al- gent prior to gradient fractionation (open bars) or spun through a layer
though preincubation of SIVmac with Triton X-100 without of detergent on top of a fractionating gradient (filled bars). In the prein-
cubation protocol, purified particles were incubated with Triton X-100fixative is sufficient to release intact SIV cores (Yu et al.,
at 47 at a 1% final concentration for 10 min, and viral lysates were then1993), we were unable to detect HIV-2ROD cores after
sedimented through a preformed 20–70% sucrose gradient. In the spin-
treatment with Triton X-100 at various concentrations thru protocol, preformed gradients were overlaid with Triton X-100 in
(Fig. 1A and data not shown). Thus, attempts to release 15% sucrose, a barrier layer in 7.5% sucrose, and purified virus. The
HIV-2 core structures from their lipid bilayers by deter- amount of Triton X-100 used in the spin-thru was 1% of the total volume
of all three layers (similarly, the total volume of the viral lysate in thegent incubation were unsuccessful.
‘‘preincubation’’ equaled the three layers). Fractions were obtained andBecause pretreatment of virions with detergent re-
analyzed for density (abscissa) and RT activity (ordinate). Density is
sulted in an almost complete solubilization of the parti- represented as the corresponding g/ml of sedimenting complexes. RT
cles, a different core isolation technique was tested activity was measured as described under Materials and Methods and
which would minimize the time that virions are incubated is represented as relative image units (RIU) above background. (B)
Same as A but with HIV-2vpx particles.in detergent. This methodology, first used in the purifica-
tion of avian myeloblastosis virus cores, has been re-
ferred to as the ‘‘spin-thru’’ technique (Stromberg, 1972).
significant solubilization of virus. By comparing the rela-In this protocol, a layer of detergent is placed on top of a
tive levels of RT detected at high densities, virus spin-thrupreformed density-separating gradient, such as sucrose.
is nearly 80-fold more efficient than virus preincubation inNext, intact virions are layered over the detergent-capped
the purification of HIV-2 cores when using the same rela-gradient. These gradient preparations are subsequently
tive amount of Triton X-100 to virus (Fig 1A).spun at high speed in an ultracentrifuge. Thus, the intact
Surprisingly, the difference between the two techniquesvirus particles enter and pass through a detergent inter-
in the efficiency of core release is less significant whenface in an extremely short period of time, effectively min-
evaluating an HIV-2 mutant which does not encode Vpx,imizing the detergent incubation time of the virus.
HIV-2vpx (Fig. 1B). In this circumstance, preincubation ofUsing the spin-thru technique, a significant enrichment
virus with Triton X-100 releases RT activity in the higherof RT activity was detected at densities between 1.23
density fractions of the gradient, although, somewhat lessand 1.27 g/ml using numerous nonionic detergents (Fig.
efficiently than with the spin-thru technique (see Discus-1A and data not shown). In all cases, most of the RT
sion).activity appeared at the top of the gradient (low-density
fractions) after spinning through detergent, suggesting However, given the clear superiority of the spin-thru
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technique in purifying wild-type HIV-2 cores, different To determine whether intact core structures were
present in the high-density fractions of sucrose whichnonionic detergents were screened at various detergent
to protein concentrations for their ability to release wild- contained a peak in RT activity and CA on immunoblots,
samples were examined using a transmission electrontype HIV-2 core structures after spin-thru. Two deter-
gents, Igepal CO-630 and Igepal CO-610 (Rhone- microscope. Negative- and positive-stained cone- and
bar-shaped structures were detected at 50,0001magnifi-Poulenc), were found to consistently release a greater
proportion of gradient pelletable RT activity using the cation (Fig. 3). Many cores appeared in a highly aggre-
gated form after purification (Fig. 3A). The tight clusteringspin-thru technique (data not shown). Thus, for optimal
isolation of wild-type HIV-2 cores necessary for Vpx local- of cores could be indicative of a highly hydrophobic exte-
rior of the individual structures. Isolated cores variedization experiments, we chose to use Igepal CO-630 in
spin-thru analyses. from 80 to 100 nm in length (Fig. 3B) (Fukui et al., 1993;
Gelderblom et al., 1987; Palmer et al., 1988). Thus, by
density, RT plus CA content, and morphology, spinningFractionation of ROD10 to assess Vpx localization
intact virion particles through a detergent layer releases
HIV-2 core structures.To ascertain the localization of Vpx within the virion
particle, the amount of virus used was increased. HIV-2 Immunoblots containing purified cores were probed
next with anti-Vpx sera to evaluate the distribution of Vpxwas spun through a layer of Igepal C0-630 into a sucrose
gradient to purify intact core structures away from lysed through the fractions. In both preparations of virus, two
Vpx-reactive bands are detected from virions after dena-virus particles. In parallel, an equal amount of the same
virus was spun through an equivalent layer which did turation and size separation, a 15- to 16-kDa species
which corresponds to the size of monomeric Vpx as wellnot contain detergent into a sucrose gradient. After sedi-
mentation, fractions were isolated and examined for RT as a protein migrating at an apparent molecular weight
of 30 kDa (Fig. 2). Both species can be detected withactivity (Fig. 2). Peak RT fractions of detergent-untreated
virus appeared in sucrose fractions corresponding to polyclonal peptide sera directed to either the amino- or
the carboxyl-terminus of Vpx although not with preim-densities of 1.15 and 1.17 g/ml (Fig. 2A), consistent with
that of intact retroviruses. In contrast, virus spun through mune sera (data not shown). Purified virus from this
strain of HIV-2 contains roughly equimolar amounts ofthe detergent layer contained significantly less RT activity
in fractions which would correspond with intact virions Vpx and CA in particles (Fig. 2A) (KewalRamani et al.,
1996). After virus is spun through detergent, the distribu-(Fig. 2B). Most of the RT activity was found at the very
top of the gradient, indicating substantial solubilization tion of Vpx still mimics that of CA (Fig. 2B). While most
Vpx is detected at the top of the gradient after viral lysis,of virions. However, a significant peak of RT activity was
also detected at higher densities of 1.24 and 1.26 g/ml. significant amounts of the protein are detected in frac-
tions 3 and 4 where the other core-associated proteinsThe banding of RT activity in the high-density fractions
of the gradient was consistent with the purification of are also detected. Significantly, the 30-kDa Vpx species
is also detected with the core structures after detergentcores.
The presence of RT in high-density fractions of the fractionation. Fractionation experiments sedimenting in
vitro-expressed and -purified Vpx protein either throughgradient indicates its association with viral nucleic acid
but does not ensure the presence of intact cores. Immu- a layer of detergent or without a detergent layer into
sucrose gradients reveal that soluble Vpx does not mi-nogold labeling of mature virions demonstrates that CA
is the major component of the core structure (Fukui et grate into the gradient and remains in the low-density
fractions at the top of the gradient (data not shown). Thus,al., 1993; Gelderblom et al., 1987). Therefore, gradient
fractions were analyzed on immunoblots with mono- these data indicate that Vpx is a core-associated protein.
clonal antibody directed to CA, which does not directly
associate with nucleic acid (Bukrinsky et al., 1993b; Far- Analysis of the 30-kDa core-associated Vpx species
net and Haseltine, 1990). As expected, untreated virus
contains the greatest concentration of CA in the same Because the higher order Vpx complex was enriched
in HIV-2 cores, it may be functionally relevant in the viralfractions which have the largest amount of RT activity
corresponding to intact retrovirions (Fig. 2A). Examination life cycle. To better understand the nature of the 30-kDa
complex, we first asked if it was a poorly reduced dimerof virus fractions spun through detergent also shows a
distribution of CA which mirrors that of RT activity (Fig. of Vpx. While treatment with a reducing agent is abso-
lutely required for detection of monomeric Vpx by SDS–2B). Most of the particle CA is lysed and found at the top
of the gradient in the low-density fractions. However, PAGE, the presence or absence of reducing agent (e.g.,
b-me) did not significantly affect the quantity or quality ofmore significantly, the high-density fractions, 3 and 4,
which contained peaks of RT activity are also enriched the Vpx 30-kDa species found in virions (Fig. 4A). Similar
results have been obtained previously with different Vpxfor CA. The presence of RT and CA in the same high-
density fractions indicates the sedimentation of core antisera (Kappes et al., 1993). In addition, treatment with
other denaturants, such as 8 M urea, or increasingcomplexes.
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FIG. 2. Fractionation of HIV-2 for biochemical analyses. (A) Different density fractions of untreated HIV-2 were tested for RT activity (top), CA
content (middle), and Vpx content (bottom). Twelve fractions were obtained after sedimentation through a 25–60% sucrose gradient and are
represented on the abscissa. An amount of HIV-2 corresponding to 100 ng HIV-1 CA, when measured with an ELISA directed toward HIV-1 CA,
was used in both sedimentations. (B) Density fractions of virus treated for core release. Virus was spun through a layer of Igepal CO-630 in the
same manner as described in the Fig. 1 legend. The top portions of A and B depict the RT activity (first ordinate) and density (second ordinate) of
the different fractions. RT activity (closed boxes) was measured using phosphorimage technology and represented as relative image units (RIU)
above background, and density (open circles) is represented as the corresponding g/ml of sedimenting complexes. Fractions were precipitated
with TCA for size separation on 15% SDS–PAGE and analysis on immunoblots. The middle portions of A and B are immunoblots of the different
fractions using monoclonal antibody directed to HIV-2 CA. The bottom portions show immunoblots using anti-Vpx peptide polyclonal serum. Weights
of molecular size markers (in kDa) are shown.
amounts of reducing agents did not appreciably de- cludes incorporation of the 30-kDa complex (Fig. 5A, lane
2). Thus, the 30-kDa complex requires the expression ofcrease the level of the 30-kDa species (data not shown).
Purification of the 30-kDa species from nonreducing the vpx orf.
Mutation of the downstream vpr gene has no effect onSDS–PAGE via electroelution indicates that the majority
of 30-kDa nonreduced Vpx species cannot be resolved the incorporation of the 30-kDa complex (Fig. 5A, lane
3). This demonstrates that the 30-kDa complex is not ainto Vpx monomers after treatment with b-me and, thus,
are not the result of a disulfide linkage (Fig. 4B). Vpx–Vpr fusion resulting from either the readthrough of
the vpx termination codon or a Vpx/Vpr complex which isWe next speculated that the 30-kDa Vpx-reactive pro-
tein might be a fusion protein whose coding sequence generated posttranslationally. The 30-kDa Vpx complex
could still arise from the fusion of the vpx orf with otherincluded the vpx open reading frame (orf). To determine
whether the 30-kDa Vpx-reactive protein could have re- viral sequences. However, if complementation of pHIV-
2vpx by expression of Vpx in trans is necessary andsulted from the readthrough of the proviral vpx termina-
tion codon or arose from aberrant splicing of the vpx sufficient for generation of the 30-kDa species in the
virion, then the complex could not be a provirally encodedRNA, human 293T cells were transfected with a wild-
type HIV-2 provirus, a provirus mutated in vpx (pHIV- fusion.
In fact, coexpression of the vpx gene using an expres-2vpx), a provirus mutated in vpr (pHIV-2vpr), or pHIV-2vpx
with Vpx supplied in trans (using pLTR-VPX) to generate sion vector, pLTR-VPX, with a different 3* untranslated
region in trans with pHIV-2vpx is sufficient to generatevirus stocks. Mutation of the vpx initiation codon pre-
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FIG. 3. Electron microscopy of HIV-2 core structures. High-density fractions (1.22–1.28 g/ml) of HIV-2 obtained from detergent spin-thru (Igepal
CO-630) were visualized at 50,000-fold magnification. Fractions were concentrated after dilution of sucrose and fixed. Fixed material was examined
under transmission EM after staining with 2% uranyl acetate. (A) Representative aggregation of cores. (B) Individual core structures. Bar represents
100 nm.
the 30-kDa complex in virions (Fig. 5A, lane 4). Thus, the and monomeric Vpx is intrinsic to the genesis of the 30-
kDa complex.30-kDa Vpx complex is not a fusion protein derived from
aberrant viral splicing or a termination readthrough event, The higher order Vpx complex is not unique to HIV-
FIG. 4. Anti-Vpx immunoblots showing the effect of reducing agents
on Vpx 30-kDa complex. (A) Purified HIV-2 was either boiled in SDS-
loading buffer with or without 1 M b-mercaptoethanol (b-me) prior to
separation on 15% SDS–PAGE. The first and second lane depicted on
the immublots are virus not treated with b-me; however, the second
lane demonstrates the partial diffusion of b-me from the third lane
which occurs during electrophoresis (Allore and Barber, 1984). (B) Pro- FIG. 5. Anti-Vpx immunoblots to determine the genetic basis of 30-
kDa Vpx complex. (A) Purified virus obtained from transfection of 293Tteins migrating at approximately 30-kDa after size-separation of nonre-
duced HIV-2 on SDS–PAGE (e.g., first lane, A) were excised, electro- cells with pHIV-2, pHIV-2vpx, pHIV-2vpr, or pHIV-2vpx plus pLTR-VPX
were size separated on 15% SDS–PAGE and analyzed on immunoblotseluted out of the gel slice, and then boiled in SDS–loading buffer with
or without 1 M b-me (as depicted) prior to separation on 15% SDS– using anti-Vpx peptide polyclonal serum (as depicted). (B) HIV-2ROD or
SIVmne obtained from infection of CEMx174 cells were analyzed for VpxPAGE. Proteins were analyzed on immunoblots using using anti-Vpx
peptide polyclonal serum. Note, this ECL immunoblot was overexposed content after SDS–PAGE and Western blotting. Virus lanes are labeled
as are concentrated supernatants obtained from ‘‘mock’’-infected cells.so monomeric Vpx is visible. Weights of molecular size markers (in
kDa) are shown. Weights of molecular size markers (in kDa) are shown.
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2. SIVmne also incorporates a similar higher order Vpx
complex whose size is a function of the size of mono-
meric Vpx (Fig. 5B). Because the size of the higher order
Vpx form in HIV-2 and SIV differs despite being propa-
gated in the same cell type, it is unlikely that the 30-kDa
species represents a virion-incorporating cellular protein
induced by Vpx. Instead, the size dependence of the 30-
kDa species on monomeric Vpx and the previous com-
plementation experiments indicate that the 30-kDa form
is probably a Vpx complex.
The abundance of the Vpx 30-kDa species in virions as
well as cores suggested its presence may be dependent
upon a high local concentration of Vpx. To test this hy-
pothesis, recombinant Vpx protein of high purity was iso-
lated on two sequential affinity chromatography matrices
and then concentrated by spin filtration for analysis on
immunoblots (Fig. 6). Dilutions of bacterially expressed
Vpx reveal a higher order Vpx-reactive band analogous
to that seen in virions at a similar level relative to mono-
FIG. 6. Spontaneous formation of Vpx dimers in vitro. (A) Silver stain-meric Vpx (Fig. 6B). The ability of highly purified Vpx
ing of purification of recombinant Vpx from its cleaved fusion partner,generated from bacteria to form a nondenaturable dimer
MBP. Affinity-purified MBP–Vpx fusion proteins were proteolyzed withstrongly suggests that the 30-kDa Vpx complex detected
biotinylated human Factor Xa which was subsequently removed with
in virions is a Vpx homodimer. In addition, Vpx translated a streptavidin matrix (Boehringer Mannheim). The cleaved products
in vitro in rabbit reticulocyte lysates also generates a 30- were adsorbed to an Orange A dyematrix resin (Amicon) in the pres-
ence of column buffer (20 mM KCl, 20 mM Tris–HCl, pH 7.5). AfterkDa nondenaturable complex (data not shown).
washing, the matrix was then treated with increasing steps of KCl (100Therefore, the 30-kDa Vpx species found in virion
mM to 2 M) buffered with 20 mM Tris–HCl, pH 7.5, and eluates werecores is probably a Vpx homodimer which results from
collected. These fractions were then analyzed by 15% SDS–PAGE and
a high local concentration of Vpx and, thus, may be a silver staining (Bio-Rad). The first lane of the gel depicts the cleaved
marker for core structures. The biochemical nature of the material which was loaded on the Orange A column. The next two
lanes represent the first and last washes of the column with columnVpx dimerization appears to be the result of a highly
buffer. The subsequent lanes represent fractions from increasing con-stable linkage. The dimerization of Vpx may be important
centrations KCl and are labeled with respect to their molarity. The MBPfor its function and, possibly, interactions with other core-
and Vpx bands are noted. After chromatography, recombinant Vpx-
associated elements during infection. containing fractions are more than 95% pure. (B) Anti-Vpx immunoblot
of dilutions of recombinant protein compared to HIV-2 dilutions. Affinity-
purified recombinant Vpx protein was desalted and concentrated toDISCUSSION
250 mg/ml by spin filtration. Proteins were size separated by SDS–
PAGE and Western blotted. Lanes a, b, and c are dilutions of recombi-Using the viral spin-thru technique to obtain retroviral
nant protein, 2.5, 0.5, and 0.1 mg, respectively. Lanes d, e, and f are
cores, we have purified HIV-2 core structures and found twofold sequential dilutions of purified HIV-2. The Vpx dimeric species
Vpx to be associated with them. Vpx which is found asso- is denoted by an asterisk. Weights of molecular size markers (in kDa)
are shown.ciated with the virion core includes both monomeric and
a nondenaturable, nonreducible higher order molecular
weight species. This 30-kDa species corresponds to the
also reported that HIV-1 cores could also be obtainedsize of dimerized monomeric HIV-2 Vpx which is 15 kDa.
with this protocol (Liu et al., 1995). In both reports, veryThe higher order Vpx species requires expression of the
large amounts of culture supernatants from infected cellsvpx orf and is not a Vpx fusion protein. A similar complex
(500 ml) were used to concentrate virus for Triton X-appears in SIV at twice the molecular weight of mono-
100 preincubations. Because only high-density materialmeric SIV Vpx. Highly purified recombinant Vpx is also
obtained from the Triton X-100 preincubations was ana-capable of forming this complex. Collectively, these data
lyzed in a second sizing gradient, the efficiency of coreindicate that Vpx homodimers or multimers are present
release in these experiments cannot be assessed. Usingin the virion core. These data corroborate coimmuno-
significantly less starting material (10 to 25 ml of cultureprecipitation experiments which demonstrate HIV-2 Vpx
supernatants), we compared the relative efficiency ofdirectly interacts with CA in mature particles (Horton et
core isolation by pretreating HIV-2 virions with Triton X-al., 1994).
100 versus spinning virus particles through an equalPurification of core structures from SIVmac , a virus
amount of Triton X-100 to minimize the detergent expo-highly related to HIV-2, has been achieved by preincuba-
sure time. By reducing the Triton X-100 exposure timetion of the virus with Triton X-100 without fixative (Yu et
al., 1993). While this article was in preparation, it was using the spin-thru technique, the yield of HIV-2 cores
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was significantly increased. Independent experiments et al., 1995; Lu et al., 1993; Park and Sodroski, 1995;
Paxton et al., 1993; Tristem et al., 1992; Westervelt et al.,with the same virus stock revealed that performing the
detergent preincubations at 47 instead of room tempera- 1992; Wu et al., 1994; Yu et al., 1991). These data would
collectively suggest a conserved mechanism for infectionture appeared to increase the core yield by 20% (data not
shown). Thus, either decreasing the detergent exposure of nondividing cells.
The significance of Vpx multimerization is not clear;time or decreasing the temperature during solubilization
reduces the stringency of the assay and, commensu- however, it is an intrinsic feature of the protein given that
Vpx dimers form at similar proportions in vivo and in vitro.rately, increases the core yield. Given the reduced
amount of virus we used in our assays, we cannot ex- Similarly, an apparently nondenaturable dimeric form of
Vpr has been reported in HIV-1 particles (Paxton et al.,clude the possibility that significantly increasing the ratio
of virus to detergent while maintaining a detergent con- 1993). The nature of the dimerization is intriguing in that
it is difficult to denature. Proteolytic analyses of the dimercentration higher than the detergent’s CMC would ulti-
mately allow release of HIV-2 cores without their com- compared to monomeric Vpx may be useful in defining
the region(s) important for multimerization. Purification ofplete solubilization.
The incorporation of Vpx in HIV-2 cores differs from proteolyzed fragments unique to the dimer would also
provide a substrate to examine the nature of the linkage.SIVmac cores (Liska et al., 1994; Yu et al., 1993). This could
either reflect an intrinsic difference between SIV and HIV- Finally, characterization of the dimerization region may
elaborate the significance of this region for the infection2 or, more likely, be a result of the different techniques
used in purifying core structures. Therefore, we considered of nonproliferating cells.
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bated with detergent than cores which incorporate more
We thank Wei Chun Goh, Peggy Lee, and Gina Stivahtis for com-Vpx. Indeed, previous isolation of SIVmac cores copurified ments on the manuscript, Peggy Lee for instruction on sucrose gradient
detectable, albeit diminished, amounts of Vpx relative to sedimentation and fractionation; and Jason Kimata and Keith Peden for
CA (Yu et al., 1993). We find that detergent preincubation molecular clones. We gratefully acknowledge the assistance received
via shared resources at FHCRC especially from Paul C. Goodwin andof HIV-2 viruses mutated in the vpx gene, and which thus
Tim Knight in the Image Analysis Laboratory and Liz Caldwell in Elec-lack Vpx, is sufficient for release of these cores. In compari-
tron Microscopy. Murine monoclonal antibody to HIV-2 p25 was contrib-son, obtaining mutant HIV-2 cores via the spin-thru tech-
uted to the National Institutes of Health AIDS Research and Reference
nique is only slightly more efficient than detergent preincu- Reagent Program by P. Yoshihara. V.N.K. was supported by a Helen
bation, as is the case for oncovirus cores (Teramoto et al., R. Whiteley graduate fellowship from the University of Washington De-
partment of Microbiology. This research was funded through R011977).
AI30927 from the National Institutes of Health.Our data suggest that Vpx incorporation increases the
detergent sensitivity of virion cores. The relative ease of
REFERENCESpurifying these cores by detergent preincubation sug-
gests that the cores of wild-type virions purified via this Allore, R. J., and Barber, B. H. (1984). A recommendation for visualizing
protocol would select for the population which contained disulfide bonding by one-dimensional sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis. Anal. Biochem. 137, 523–527.significantly less Vpx than the typical wild-type particle.
Balliet, J. W., Kolson, D. L., Eiger, G., Kim, F. M., McGann, K. A., Sriniva-In fact, the inefficiency of purifying wild-type HIV-2 cores
san, A., and Collman, R. (1994). Distinct effects in primary macro-by detergent preincubation (1% starting material) indi-
phages and lymphocytes of the human immunodeficiency virus type
cates that any population of cores isolated may not be 1 accessory genes vpr, vpu, and nef: Mutational analysis of a primary
representative of the wild-type population. Thus, the in- HIV-1 isolate. Virology 200, 623–631.
Borroto-Esoda, K., and Boone, L. R. (1991). Equine infectious anemiaability to readily detect SIV Vpx in virion cores may be
virus and human immunodeficiency virus DNA synthesis in vitro:due to the intrinsic instability of cores containing Vpx
Characterization of the endogenous reverse transcriptase reaction.which are eliminated in a more stringent fractionation
J. Virol. 65, 1952–1959.
procedure resulting in the small population of cores Bowerman, B., Brown, P. O., Bishop, J. M., and Varmus, H. E. (1989). A
whose virions had failed to efficiently incorporate Vpx. nucleoprotein complex mediates the integration of retroviral DNA.
Genes Dev. 3, 469–478.The association of Vpx with HIV-2 cores correlates
Bukrinsky, M. I., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubel, A.,with the association of Vpr with the HIV-1 preintegration
Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., and Stevenson, M.complex (Heinzinger et al., 1994). These results suggest
(1993a). A nuclear localization signal within HIV-1 matrix protein that
that HIV-2 Vpx may also be associated with the preinte- governs infection of nondividing cells. Nature (London) 365, 666–669.
gration complex. HIV-2 Vpx and HIV-1 Vpr are both effi- Bukrinsky, M. I., Sharova, N., McDonald, T. L., Pushkarskaya, T., Tarpley,
W. G., and Stevenson, M. (1993b). Association of integrase, matrix,ciently incorporated into virions via the C-terminal end
and reverse transcriptase antigens of human immunodeficiency virusof their respective Gag proteins, share a common evolu-
type 1 with viral nucleic acids following acute infection. Proc. Natl.tionary origin, and are both important for infection of tis-
Acad. Sci. USA 90, 6125–6129.
sue macrophages (Balliet et al., 1994; Connor et al., 1995; Chen, C., and Okayama, H. (1987). High-efficiency transformation of
Gibbs et al., 1994; Guyader et al., 1989; Heinzinger et al., mammalian cells by plasmid DNA. Mol. Cell. Biol. 7(8), 2745–2752.
Coffin, J. M., and Temin, H. M. (1971). Comparison of Rous sarcoma1994; Kappes et al., 1991; Kawamura et al., 1994; Kondo
AID VY 7827 / 6a13$$$441 02-29-96 22:37:22 viral AP: Virology
168 KEWALRAMANI AND EMERMAN
virus-specific deoxyribonucleic acid polymerases in virions of Rous Kondo, E., Mammano, F., Cohen, E. A., and Gottlinger, H. G. (1995).
The p6gag domain of human immunodeficiency virus type 1 is suffi-sarcoma virus and in Rous sarcoma virus-infected chicken cells. J.
Virol. 7, 625–634. cient for the incorporation of Vpr into heterologous viral particles. J.
Virol. 69, 2759–2764.Cohen, E. A., Dehni, G., Sodroski, J. G., and Haseltine, W. A. (1990).
Human immunodeficiency virus vpr product is a virion-associated Liska, V., Spehner, D., Mehtali, M., Schmitt, D., Kirn, A., and Aubertin,
A. M. (1994). Localization of viral protein X in simian immunodefi-regulatory protein. J. Virol. 64, 3097–3099.
Connor, R. I., Chen, B. K., Choe, S., and Landau, N. R. (1995). Vpr is ciency virus macaque strain and analysis of its packaging require-
ments. J. Gen. Virol. 75, 2955–2962.required for efficient replication of human immunodeficiency virus
type-1 in mononuclear phagocytes. Virology 206, 935–944. Liu, H., Wu, X., Newman, M., Shaw, G. W., Hahn, B. H., and Kappes,
J. C. (1995). The Vif protein of human and simian immunodeficiencyDedera, D., Hu, W., Vander, H. N., and Ratner, L. (1989). Viral protein
R of human immunodeficiency virus types 1 and 2 is dispensable viruses is packaged into virions and associates with viral core struc-
tures. J. Virol. 69, 7630–7638.for replication and cytopathogenicity in lymphoid cells. J. Virol. 63,
3205–3208. Lu, Y. L., Spearman, P., and Ratner, L. (1993). Human immunodeficiency
virus type 1 viral protein R localization in infected cells and virions.Emerman, M., Bukrinsky, M., and Stevenson, M. (1994). HIV infection
of non-dividing cells. Nature (London) 369, 107–108. J. Virol. 67, 6542–6550.
Myers, G., Wain-Hobson, S., Henderson, L. E., Korber, B., Jeang, K.-T.,Farnet, C. M., and Haseltine, W. A. (1990). Integration of human immuno-
deficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. USA 87, and Pavlakis, G. N., Eds. (1994). ‘‘Human Retroviruses and AIDS,
1994.’’ Los Alamos National Laboratory, Los Alamos, NM.4164–4168.
Fukui, T., Imura, S., Goto, T., and Nakai, M. (1993). Inner architecture of Palmer, E., Martin, M. L., Goldsmith, C., and Switzer, W. (1988). Ultra-
structure of human immunodeficiency virus type 2. J. Gen. Virol. 69,human and simian immunodeficiency viruses. Microsc. Res. Technol.
25(4), 335–340. 1425–1429.
Park, I. W., and Sodroski, J. (1995). Functional analysis of the vpx, vpr,Gallay, P., Swingler, S., Aiken, C., and Trono, D. (1995). HIV-1 infection
of nondividing cells: C-terminal tyrosine phosphorylation of the viral and nef genes of simian immunodeficiency virus. J. AIDS 8, 335–
344.matrix protein is a key regulator. Cell 80, 379–388.
Gelderblom, H. R., Hausmann, E. H., Ozel, M., Pauli, G., and Koch, Paxton, W., Connor, R. I., and Landau, N. R. (1993). Incorporation of Vpr
into human immunodeficiency virus type 1 virions: Requirement forM. A. (1987). Fine structure of human immunodeficiency virus (HIV)
and immunolocalization of structural proteins. Virology 156, 171– the p6 region of gag and mutational analysis. J. Virol. 67, 7229–7237.
Roberts, M. M., and Oroszlan, S. (1989). The preparation and biochemi-176.
Gibbs, J. S., Regier, D. A., and Desrosiers, R. C. (1994). Construction and cal characterization of intact capsids of equine infectious anemia
virus. Biochem. Biophys. Res. Commun. 160, 486–494.in vitro properties of SIVmac mutants with deletions in ‘‘nonessential’’
genes. AIDS Res. Hum. Retroviruses 10(4), 333–342. Ryan-Graham, M. A., and Peden, K. W. C. (1995). Both virus and host
components are important for the manifestation of a Nef- phenotypeGoff, S., Traktman, P., and Baltimore, D. (1981). Isolation and properties
of Moloney murine leukemia virus mutants: Use of a rapid assay for in HIV-1 and HIV-2. Virology 213, 158–168.
Stromberg, K. (1972). Surface-active agents for isolation of the corerelease of virion reverse transcriptase. J. Virol. 38, 239–248.
Guyader, M., Emerman, M., Montagnier, L., and Peden, K. (1989). VPX component of avian myeloblastosis virus. J. Virol. 9, 684–697.
Stromberg, K., Hurley, N. E., Davis, N. L., Rueckert, R. R., and Fleissner,mutants of HIV-2 are infectious in established cell lines but display
a severe defect in peripheral blood lymphocytes. EMBO J. 8(4), 1169– E. (1974). Structural studies of avian myeloblastosis virus: Compari-
son of polypeptides in virion and core component by dodecyl sulfate–1175.
Heinzinger, N. K., Bukinsky, M. I., Haggerty, S. A., Ragland, A. M., KewalRa- polyacrylamide gel electrophoresis. J. Virol. 13, 513–528.
Teramoto, Y. A., Cardiff, R. D., and Lund, J. K. (1977). The structure ofmani, V., Lee, M. A., Gendelman, H. E., Ratner, L., Stevenson, M., and
Emerman, M. (1994). The Vpr protein of human immunodeficiency virus the mouse mammary tumor virus: Isolation and characterization of
the core. Virology 77, 135–148.type 1 influences nuclear localization of viral nucleic acids in nondividing
host cells. Proc. Natl. Acad. Sci. USA 91, 7311–7315. Tristem, M., Marshall, C., Karpas, A., and Hill, F. (1992). Evolution of
the primate lentiviruses: Evidence from vpx and vpr. EMBO J. 11,Henderson, L. E., Sowder, R. C., Copeland, T. D., Beneveniste, R. E.,
and Oroszlan, S. (1988). Isolation and characterization of a novel 3405–3412.
von Schwedler, U., Kornbluth, R. S., and Trono, D. (1994). The nuclearprotein (x-orf product) from SIV and HIV-2. Science 241, 199–201.
Horton, R., Spearman, P., and Ratner, L. (1994). HIV-2 viral protein X associ- localization signal of the matrix protein of human immunodeficiency
virus type 1 allows the establishment of infection in macrophagesation with the GAG p27 capsid protein. Virology 199, 453–457.
Hu, S. L., Stallard, V., Abrams, K., Barber, G. N., Kuller, L., Langlois, and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 6992–
6996.A. J., Morton, W. R., and Benveniste, R. E. (1993). Protection of vac-
cinia-primed macaques against SIVmne infection by combination Westervelt, P., Henkel, T., Trowbridge, D. B., Orenstein, J., Heuser, J.,
Gendelman, H. E., and Ratner, L. (1992). Dual regulation of silentimmunization with recombinant vaccinia virus and SIVmne gp160. J.
Med. Primatol. 22(2–3), 92– 99. and productive infection in monocytes by distinct human immunodefi-
ciency virus type 1 determinants. J. Virol. 66, 3925–3931.Kappes, J. C., Conway, J. A., Lee, S. W., Shaw, G. M., and Hahn, B. H.
(1991). Human immunodeficiency virus type 2 vpx protein augments Wu, X., Conway, J. A., Kim, J., and Kappes, J. C. (1994). Localization
of the Vpx packaging signal within the C terminus of the humanviral infectivity. Virology 184, 197–209.
Kappes, J. C., Parkin, J. S., Conway, J. A., Kim, J., Brouillette, C. G., immunodeficiency virus type 2 Gag precursor protein. J. Virol. 68,
6161–6169.Shaw, G. M., and Hahn, B. H. (1993). Intracellular transport and virion
incorporation of vpx requires interaction with other virus type-specific Yu, X., Matsuda, Z., Yu, Q. C., Lee, T. H., and Essex, M. (1993). Vpx of
simian immunodeficiency virus is localized primarily outside the viruscomponents. Virology 193, 222–233.
Kawamura, M., Sakai, H., and Adachi, A. (1994). Human immunodefi- core in mature virions. J. Virol. 67, 4386–4390.
Yu, X. F., Yu, Q. C., Essex, M., and Lee, T. H. (1991). The vpx gene ofciency virus Vpx is required for the early phase of replication in
peripheral blood mononuclear cells. Microbiol. Immunol. 38(11), simian immunodeficiency virus facilitates efficient viral replication in
fresh lymphocytes and macrophage. J. Virol. 65, 5088–5091.871–878.
KewalRamani, V. N., Park, C. S., Gallombardo, P. A., and Emerman, M. Yuan, X., Matsuda, Z., Matsuda, M., Essex, M., and Lee, T. H. (1990).
Human immunodeficiency virus vpr gene encodes a virion-associ-(1996). Protein stability influences human immunodeficiency virus
type 2 vpr virion incorporation and cell cycle effect. Virology, in press. ated protein. AIDS Res. Hum. Retroviruses 6(11), 1265–1271.
AID VY 7827 / 6a13$$$441 02-29-96 22:37:22 viral AP: Virology
